[1]
|
Shaw, L.M., Korecka, M., Clark, C.M., Lee, V.M. and Trojanowski, J.Q. (2007) Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nature Reviews Drug Discovery, 6, 295-303.
doi:10.1038/nrd2176
|
[2]
|
Thal, L.J., Kantarci, K., Reiman, E.M., Klunk, W.E., Weiner, M.W., Zetterberg, H., Galasko, D., Pratico, D., Griffin, S., Schenk, D. and Siemers, E. (2006) The role of biomarkers in clinical trials for Alzheimer disease. Alzheimer Disease and Associated Disorders, 20, 6-15.
doi:10.1097/01.wad.0000191420.61260.a8
|
[3]
|
Mayeux, R., Honig, L.S., Tang, M.X., Manly, J., Stern, Y., Schupf, N. and Mehta, P.D. (2003) Plasma A[beta]40 and A[beta]42 and Alzheimer’s disease: Relation to age, mortality, and risk. Neurology, 61, 1185-1190.
doi:10.1212/01.WNL.0000091890.32140.8F
|
[4]
|
Luis, C.A., Abdullah, L., Paris, D., Quadros, A., Mullan, M., Mouzon, B., Ait-Ghezala, G. and Crawford, F. (2009) Serum beta-amyloid correlates with neuropsychological impairment. Aging, Neuropsychology, and Cognition: A Journal on Normal and Dysfunctional Development, 16, 203-218. doi:10.1080/13825580802411766
|
[5]
|
Laske, C., Stransky, E., Leyhe, T., Eschweiler, G.W., Wittorf, A., Richartz, E., Bartels, M., Buchkremer, G. and Schott, K. (2006) Stage-dependent BDNF serum concentrations in Alzheimer’s disease. Journal of Neural Transmission, 113, 1217-1224.
doi:10.1007/s00702-005-0397-y
|
[6]
|
O’Bryant, S.E., Hobson, V.L., Hall, J.R., Barber, R.C., Zhang, S., Johnson, L. and Diaz-Arrastia, R. (2011) Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer’s disease cases. Dementia and Geriatric Cognitive Disorders, 31, 31-36. doi:10.1159/000321980
|
[7]
|
Waring, S., O’Bryant, S.E., Reisch, J.S., Diaz-Arrastia, R., Knebl, J. and Doody, R. (2008) The Texas Alzheimer’s Research Consortium longitudinal research cohort: Study design and baseline characteristics. Texas Public Health Journal, 60, 9-13.
|
[8]
|
McKhann, D., Drockman, D. and Folstein, M., et al. (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group. Neurology, 34, 939-944. doi:10.1212/WNL.34.7.939
|
[9]
|
R Development Core Team (2009) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, 409.
|
[10]
|
Zhang, F. and Drabier, R. (2012) IPAD: The integrated pathway analysis database for systematic enrichment analysis. BMC Bioinformatics, 13, S7.
doi:10.1186/1471-2105-13-S15-S7
|
[11]
|
Mehta, C.R., Patel, N.R. and Tsiatis, A.A. (1984) Exact significance testing to establish treatment equivalence with ordered categorical data. Biometrics, 40, 819-825.
doi:10.2307/2530927
|
[12]
|
Komulainen, P., Lakka, T.A., Kivipelto, M., Hassinen, M., Penttila, I.M., Helkala, E.L., Gylling, H., Nissinen, A. and Rauramaa, R. (2007) Serum high sensitivity C-reactive protein and cognitive function in elderly women. Age & Ageing, 36, 443-448. doi:10.1093/ageing/afm051
|
[13]
|
Schmidt, R., Schmidt, H., Curb, J.D., Masaki, K., White, L.R. and Launer, L.J. (2002) Early inflammation and dementia: A 25-year follow-up of the Honolulu-Asia aging study. Annals of Neurology, 52, 168-174.
doi:10.1002/ana.10265
|
[14]
|
Newman, A.B., Fitzpatrick, A.L., Lopez, O., Jackson, S., Lyketsos, C., Jagust, W., Ives, D., Dekosky, S.T. and Kuller, L.H. (2005) Dementia and Alzheimer’s disease incidence in relationship to cardiovascular disease in the cardiovascular health study cohort. Journal of the American Geriatrics Society, 53, 1101-1107.
doi:10.1111/j.1532-5415.2005.53360.x
|
[15]
|
Engelhart, M.J., Geerlings, M.I., Meijer, J., Kiliaan, A., Ruitenberg, A., van Swieten, J.C., Stijnen, T., Hofman, A., Witteman, J.C.M. and Breteler, M.M.B. (2004) Inflammatory proteins in plasma and the risk of dementia: The Rotterdam study. Archives of Neurology, 61, 668-672.
doi:10.1001/archneur.61.5.668
|
[16]
|
Wright, C.B., Sacco, R.L., Rundek, T.R., Delman, J.B., Rabbani, L.E. and Elkind, M.S.V. (2006) Interleukin-6 is associated with cognitive function: The Northern Manhattan study. Journal of Stroke and Cerebrovascular Disease, 15, 34-38.
doi:10.1016/j.jstrokecerebrovasdis.2005.08.009
|
[17]
|
Yaffe, K., Lindquist, K., Penninx, B.W., Simonsick, E.M., Pahor, M., Kritchevsky, S., Launer, L., Kuller, L., Rubin, S. and Harris, T. (2003) Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology, 61, 76-80.
doi:10.1212/01.WNL.0000073620.42047.D7
|
[18]
|
Bruunsgaard, H., Andersen-Ranberg, K., Jeune, B., Pedersen, A.N., Skinhoj, P. and Pedersen, B.K. (1999) A high plasma concentration of TNF-alpha is associated with dementia in centarians. Journal of Gerentology Series A: Biological Sciences Medical Sciences, 54, M357- M364. doi:10.1093/gerona/54.7.M357
|
[19]
|
Dik, M.G., Jonker, C., Hack, C.E., Smit, J.H., Comijs, H.C. and Eikelenboom, P. (2005) Serum inflammatory proteins and cognitive decline in older persons. Neurology, 64, 1371-1377.
doi:10.1212/01.WNL.0000158281.08946.68
|
[20]
|
O’Bryant, S.E., Hobson, V.L., Hall, J.R., Barber, R.C., Zhang, S., Johnson, L. and Diaz-Arrastia, R. (2011) Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer’s disease cases. Dementia and Geriatric Cognitive Disorders, 31, 31-36. doi:10.1159/000321980
|
[21]
|
O’Bryant, S.E., Xiao, G., Barber, R., Huebinger, R., Wilhelmsen, K., Edwards, M., Graff-Radford, N., Doody, R. and Diaz-Arrastia, R. (2011) A blood-based screening tool for Alzheimer’s disease that spans serum and plasma: Findings from TARC and ADNI. PLOS One, 6, e28092.
doi:10.1371/journal.pone.0028092
|